Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
United Therapeutics
UTHR
$26.3B
| $92.5M | 0.03% |
531,506
+69,672
| +15% | +$12.5M |
|
702
Empire State Realty Trust
ESRT
$969M
| $92.3M | 0.03% |
5,411,305
-12,427
| -0.2% | -$224K |
|
703
Liberty Media Series C
FWONK
$24.6B
| $92.3M | 0.03% |
3,632,976
-742,299
| -17% | -$20M |
|
704
CALL
Oracle
ORCL
$345B
| $92.3M | 0.03% |
2,290,000
-782,400
| -25% | -$33.9M |
|
705
CALL
Home Depot
HD
$335B
| $92.3M | 0.03% |
830,200
-87,100
| -9% | -$9.75M |
|
706
PTC
PTC
$14.5B
| $92M | 0.03% |
2,243,884
+1,042,400
| +87% | +$41.2M |
|
707
PUT
Macy's
M
$6.57B
| $92M | 0.03% |
1,364,200
+664,100
| +95% | +$44.9M |
|
708
Teva Pharmaceuticals
TEVA
$36.2B
| $92M | 0.03% |
1,556,108
+4,339
| +0.3% | +$268K |
|
|
AIRM
709
DELISTED
Air Methods Corp
AIRM
| $91.8M | 0.03% |
2,221,710
+341,639
| +18% | +$15M |
|
710
Encompass Health
EHC
$11.3B
| $91.8M | 0.03% |
2,504,246
-74,757
| -3% | -$2.67M |
|
711
Live Nation Entertainment
LYV
$41.7B
| $91.8M | 0.03% |
3,337,882
+257,839
| +8% | +$7.04M |
|
712
TripAdvisor
TRIP
$1.66B
| $91.7M | 0.03% |
1,051,949
-23,520
| -2% | -$1.91M |
|
713
Ecolab
ECL
$76.4B
| $91.2M | 0.03% |
806,838
-19,982
| -2% | -$2.3M |
|
|
RAI
714
CALL
DELISTED
Reynolds American Inc
RAI
| $90.9M | 0.03% |
2,434,270
+551,070
| +29% | +$20.6M |
|
715
NGL Energy Partners
NGL
$1.87B
| $90.7M | 0.03% |
2,989,574
-111,488
| -4% | -$3.28M |
|
716
PUT
Merck
MRK
$323B
| $90.7M | 0.03% |
1,669,150
+533,642
| +47% | +$29.9M |
|
717
Nucor
NUE
$56.4B
| $90.6M | 0.03% |
2,056,718
+667,764
| +48% | +$32M |
|
718
Alaska Air
ALK
$5.3B
| $90.4M | 0.03% |
1,403,184
+352,169
| +34% | +$22.7M |
|
719
CALL
Halliburton
HAL
$26.8B
| $90.2M | 0.03% |
2,094,000
-304,200
| -13% | -$14M |
|
|
UN
720
DELISTED
Unilever NV New York Registry Shares
UN
| $89.9M | 0.03% |
2,147,945
+219,051
| +11% | +$9.45M |
|
721
Becton Dickinson
BDX
$43.8B
| $89.9M | 0.03% |
650,299
+95,659
| +17% | +$13.2M |
|
722
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $89.7M | 0.03% |
1,842,416
+423,107
| +30% | +$20.6M |
|
|
CADE
723
DELISTED
Cadence Bank
CADE
| $89.6M | 0.03% |
3,480,138
+35,852
| +1% | +$885K |
|
724
Kohl's
KSS
$2.1B
| $89.4M | 0.03% |
1,427,134
+351,581
| +33% | +$24.4M |
|
|
MRSH
725
Marsh
MRSH
$87.5B
| $89.3M | 0.03% |
1,574,370
-283,895
| -15% | -$16.4M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.